{"schema_version":"secwatch.filing_event.v1","accession":"0001140361-26-029541","form_type":"8-K","ticker":"LSTA","cik":"0000320017","company_name":"LISATA THERAPEUTICS, INC.","filed_at":"2026-07-24T16:15:36+00:00","discovered_at":"2026-07-24T16:16:00.731750+00:00","generated_at":"2026-07-24T16:16:03.865090+00:00","sec_items":["1.02","8.01"],"event_type":"other_material","sentiment":"negative","materiality_score":0.8,"calibrated_materiality_score":0.8,"confidence":"high","headline":"Lisata Therapeutics terminates merger with Kuva Labs; Kuva failed to secure financing","bullets":["Merger agreement terminated after Kuva Labs failed to obtain financing to fund tender offer.","Kuva must pay Lisata a $2M termination fee under the agreement.","Lisata reserves rights to seek damages for willful breach; no assurance of recovery.","Board to assess strategic alternatives including reverse merger, business combination, asset sales, or dissolution.","No timetable set for strategic review; no assurance of any transaction."],"urls":{"canonical":"https://secwatch.observer/filing/0001140361-26-029541","json":"https://secwatch.observer/filing/0001140361-26-029541.json","markdown":"https://secwatch.observer/filing/0001140361-26-029541.md","text":"https://secwatch.observer/filing/0001140361-26-029541.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/320017/000114036126029541/0001140361-26-029541-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/320017/000114036126029541/ef20078724_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-07-24T16:16:03.865090+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}